Weight loss and UTI risk reduction Obesity is an independent risk factor for UTIs
Organ Protection Preclinical research demonstrates hepatoprotective, cardioprotective, and neuroprotective effects suggesting benefits that extend beyond musculoskeletal healing
Mitochondrial genome instability promotes mtDNA release that engages cGAS-STING and elevates interferon-stimulated gene expression, strengthening antiviral defense, but prolonged activation provides a route to excessive inflammatory signaling that can contribute to immunopathology during infection (122)
This exposes manufacturers to potentially heightened liability risks, particularly in the US, where a litigious culture increases the risk and financial impact of legal challenges
Westermark P, Andersson A, Westermark GT
These issues now form the foundation of coordinated legal actions involving Trulicity and other GLP-1 medications: Trulicity, Ozempic, and Mounjaro are all GLP-1 receptor agonists approved to treat type 2 diabetes